You have 9 free searches left this month | for more free features.

Refractory or intolerant to Mycosis Fungoides and sezary syndrome

Showing 26 - 50 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma, Angioimmunoblastic T-cell Lymphoma Trial in

Completed
  • Adult Nasal Type Extranodal NK/T-cell Lymphoma
  • +20 more
  • Scottsdale, Arizona
  • +1 more
May 6, 2022

Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia in

Active, not recruiting
  • Accelerated Phase Chronic Myelogenous Leukemia
  • +125 more
  • tetanus-CMV fusion peptide vaccine
  • laboratory biomarker analysis
  • Duarte, California
    City of Hope Medical Center
Feb 28, 2022

Lymphoma Trial in Stanford, Chicago, Houston (lenalidomide)

Completed
  • Lymphoma
  • Stanford, California
  • +2 more
Nov 13, 2020

Adult Lymphocyte Depletion Hodgkin Lymphoma, Adult Lymphocyte Predominant Hodgkin Lymphoma, Adult Mixed Cellularity Hodgkin

Active, not recruiting
  • Adult Lymphocyte Depletion Hodgkin Lymphoma
  • +16 more
  • 6,8-bis(benzylthio)octanoic acid
  • bendamustine hydrochloride
  • Winston-Salem, North Carolina
  • +1 more
Apr 8, 2022

Adult Grade III Lymphomatoid Granulomatosis, Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma

Terminated
  • Adult Grade III Lymphomatoid Granulomatosis
  • +116 more
  • brentuximab vedotin
  • +2 more
  • Chicago, Illinois
  • +2 more
Aug 30, 2021

Adenoid Cystic Skin Carcinoma, Adnexal Carcinoma, Anaplastic Large Cell Lymphoma, ALK-Negative Trial in United States

Recruiting
  • Adenoid Cystic Skin Carcinoma
  • +38 more
  • Biopsy
  • +6 more
  • Los Angeles, California
  • +35 more
Jan 31, 2023

Myelodysplastic Syndrome, Previously Treated Myelodysplastic Syndrome, Recurrent Adult Acute Myeloid Leukemia Trial in

Recruiting
  • Myelodysplastic Syndrome
  • +16 more
  • Computed Tomography
  • +6 more
  • Scottsdale, Arizona
  • +2 more
Feb 3, 2022

T-cell Lymphoma, NK-Cell Lymphoma, T-cell Prolymphocytic Leukemia Trial in United States (Optional Blood Sample, Optional Nail

Recruiting
  • T-cell Lymphoma
  • +30 more
  • Optional Blood Sample
  • Optional Nail Sample
  • Duarte, California
  • +25 more
Jul 28, 2023

Cutaneous T-Cell Lymphomas Trial in Dallas (TSEBT, TSEBT and pembrolizumab)

Withdrawn
  • Cutaneous T-Cell Lymphomas
  • TSEBT
  • TSEBT and pembrolizumab
  • Dallas, Texas
    University of Texas Southwestern Medical Center
Apr 20, 2020

Mycosis Fungoides, Sezary Syndrome Trial run by the NHLBI (A matched peripheral donor stem cells, cyclosporine, fludarabine)

Completed
  • Mycosis Fungoides
  • Sezary Syndrome
  • A matched peripheral donor stem cells
  • +3 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Mar 2, 2020

Mycosis Fungoides Trial in Houston (Brentuximab vedotin)

Recruiting
  • Mycosis Fungoides
  • Brentuximab vedotin
  • Houston, Texas
    MD Anderson Cancer Center
Oct 14, 2022

T-Cell Lymphoma, Peripheral T-Cell Lymphoma Refractory, Cutaneous T-Cell Lymphoma Refractory Trial in United States (LB1901)

Active, not recruiting
  • T-Cell Lymphoma
  • +4 more
  • LB1901
  • Rochester, Minnesota
  • +3 more
Feb 15, 2022

Recurrent Mycosis Fungoides and Sezary Syndrome, Refractory Mycosis Fungoides and Sezary Syndrome, Stage IB Mycosis Fungoides

Completed
  • Recurrent Mycosis Fungoides and Sezary Syndrome
  • +8 more
  • Laboratory Biomarker Analysis
  • Pembrolizumab
  • Palo Alto, California
  • +7 more
Aug 29, 2019

Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma, Angioimmunoblastic T-cell Lymphoma Trial in

Completed
  • Adult Nasal Type Extranodal NK/T-cell Lymphoma
  • +18 more
  • Scottsdale, Arizona
  • +1 more
Sep 28, 2020

Hematopoietic/Lymphoid Cancer, Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission

Completed
  • Hematopoietic/Lymphoid Cancer
  • +135 more
  • beclomethasone dipropionate
  • +4 more
  • Hackensack, New Jersey
  • +1 more
Feb 1, 2021

Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia in Remission, Adult Acute Myeloid Leukemia With

Active, not recruiting
  • Adult Acute Lymphoblastic Leukemia in Remission
  • +46 more
  • Philadelphia, Pennsylvania
    Thomas Jefferson University
Feb 10, 2021

Mycosis Fungoides, Sézary Syndrome Trial in Richmond (TSEB Therapy, Brentuximab vedotin)

Completed
  • Mycosis Fungoides
  • Sézary Syndrome
  • TSEB Therapy
  • Brentuximab vedotin
  • Richmond, Virginia
    Virginia Commonwealth University/Massey Cancer Center
Aug 29, 2019

Extracorporeal Photopheresis in Sezary Syndrome

Recruiting
  • Sezary Syndrome
  • Extracorporeal photopheresis (ECP)
  • Methoxsalen Injection
  • Pittsburgh, Pennsylvania
    University of Pittsburgh Medical Center
Aug 12, 2022

Mycosis Fungoides Trial in Istanbul (biopsy)

Recruiting
  • Mycosis Fungoides
  • biopsy
  • Istanbul, Turkey
    Bezmialem Vakif University Hospital
Jun 6, 2023

Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma, Angioimmunoblastic T-cell Lymphoma Trial in

Completed
  • Adult Nasal Type Extranodal NK/T-cell Lymphoma
  • +35 more
  • Akt inhibitor MK2206
  • laboratory biomarker analysis
  • Houston, Texas
    M D Anderson Cancer Center
Oct 14, 2020

Advanced Malignancies Trial in Denmark, Hungary, Russian Federation (BI-1808, Pembrolizumab 25 Mg/mL Solution for Injection)

Recruiting
  • Advanced Malignancies
  • BI-1808
  • Pembrolizumab 25 Mg/mL Solution for Injection
  • Copenhagen, Denmark
  • +11 more
Sep 9, 2022

Refractory Mycosis Fungoides Trial in Scottsdale (drug, other, radiation)

Completed
  • Refractory Mycosis Fungoides
  • Aminolevulinic Acid Hydrochloride
  • +3 more
  • Scottsdale, Arizona
    Mayo Clinic in Arizona
Jan 3, 2023

Remitoro in Recurrent or Refractory Peripheral T Cell Lymphoma

Recruiting
  • Lymphoma, T-cell, Peripheral
  • Lymphoma, T-cell, Cutaneous
  • Nagoya, Japan
  • +2 more
Nov 24, 2022

Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma, Recurrent Mycosis Fungoides/Sezary Syndrome, Stage I Cutaneous T-cell

Terminated
  • Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma
  • +13 more
  • Chicago, Illinois
    Northwestern University
Jul 24, 2019

Cutaneous T Cell Lymphoma, Mycosis Fungoides Trial (Hypericin, Visible Light)

Not yet recruiting
  • Cutaneous T Cell Lymphoma
  • Mycosis Fungoides
  • (no location specified)
May 23, 2023